Marjorie C. Gondre-Lewis to Opioid-Related Disorders
This is a "connection" page, showing publications Marjorie C. Gondre-Lewis has written about Opioid-Related Disorders.
Connection Strength
0.180
-
Sharafshah A, Lewandrowski KU, Elman I, Baron D, Thanos PK, Hanna C, Gold MS, Badgaiyan RD, Cadet JL, Modestino EJ, Braverman ER, Dennen CA, Makale M, Sunder K, Murphy KT, Bowirrat A, Pinhasov A, Gondre-Lewis M, Gardner E, Sipple D, Jafari N, Zeine F, Khalsa J, Fiorelli RKA, Blum K. A Comprehensive 4-layered In Silico Pharmacogenomics Analysis of the Genetic Addiction Risk Severity (GARS) Test: Strong Genetic Evidence Supporting GARS as a Novel Personalized Pre-addiction Assessment Tool in the Opioid Crisis Era. Curr Pharm Biotechnol. 2025; 26(13):2153-2180.
Score: 0.180